CAPS Rating

mitchdowd (< 20)

Results 1 - 20 of 61 : 1 2 3 4 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
30/05/2013 SBY.US 4 out of 5 Outperform 5Y $18.25 $16.68 (-0.12%) -8.60% -0.41% -8.19
16/05/2012 CGR.US 3 out of 5 Outperform 5Y $0.58 $0.27 (-0.41%) -54.00% +23.87% -77.87
14/05/2012 JAGGF.US 2 out of 5 Outperform 5Y $1.43 $0.39 (-1.03%) -73.10% +23.42% -96.53
19/04/2012 CEL.US 4 out of 5 Outperform 5Y $11.30 $9.25 (-1.60%) -18.12% +19.33% -37.45
19/04/2012 PRMW.US 4 out of 5 Outperform 5Y $1.60 $1.72 (-2.82%) +7.50% +19.40% -11.90
19/04/2012 LIME.US 3 out of 5 Outperform 5Y $2.91 $0.72 (+0.01%) -75.26% +19.89% -95.15
18/04/2012 AAV.US 4 out of 5 Outperform 5Y $2.99 $4.29 (-0.23%) +43.47% +19.27% +24.21
19/04/2012 GDFZY.US 5 out of 5 Outperform 5Y $22.33 $21.12 (+0.72%) -5.40% +19.92% -25.31
30/04/2012 GSB.US No stars Outperform 5Y $1.83 $1.63 (-0.61%) -10.73% +18.32% -29.05
18/04/2012 LYSDY.US 5 out of 5 Outperform 5Y $1.13 $0.43 (+5.08%) -61.96% +19.60% -81.56
02/04/2012 SVU.US 3 out of 5 Outperform 5Y $5.56 $6.49 (+4.34%) +16.79% +16.59% +0.19
22/05/2012 HNSN.US 4 out of 5 Outperform 5Y $2.32 $1.64 (+1.86%) -29.31% +24.97% -54.28
22/05/2012 PACB.US 3 out of 5 Outperform 5Y $2.22 $2.80 (-3.11%) +26.13% +25.15% +0.98
29/05/2012 CYTK.US 3 out of 5 Outperform 5Y $0.91 $1.89 (+29.45%) +107.92% +24.68% +83.24
19/03/2013 MACK.US 5 out of 5 Outperform 5Y $6.07 $6.39 (+0.16%) +5.27% +6.68% -1.41
18/03/2013 AAPL.US 4 out of 5 Outperform 5Y $446.01 $431.77 (-0.05%) -3.19% +6.79% -9.98
25/09/2012 URRE.US 2 out of 5 Outperform 5Y $5.29 $2.53 (-0.40%) -52.21% +13.39% -65.60
24/09/2012 ALXA.US 2 out of 5 Outperform 5Y $4.61 $4.53 (-1.31%) -1.74% +14.04% -15.78
20/09/2012 NPSP.US 4 out of 5 Outperform 5Y $8.66 $15.33 (+2.89%) +77.02% +13.52% +63.50
20/09/2012 DVAX.US 3 out of 5 Outperform 5Y $4.76 $1.04 (-5.45%) -78.15% +13.52% -91.67
Results 1 - 20 of 61 : : 1 2 3 4 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.